|
Index of reports
> Death (4)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Namenda (Memantine) death. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Namenda side effects in male
Reported by a physician from United States on 2011-12-15
Patient: male
Reactions: Haemorrhage Intracranial
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Namenda
Possible Namenda side effects in male
Reported by a pharmacist from United States on 2011-12-09
Patient: male
Reactions: Drug Level Increased, Myocardial Infarction
Adverse event resulted in: death
Drug(s) suspected as cause:
Namenda
Other drugs received by patient: Donepezil HCL; Quetiapine Fumarate; Pioglitazone; Darifenacin; Sitagliptin
Possible Namenda side effects in male
Reported by a pharmacist from United States on 2011-12-02
Patient: male
Reactions: Drug Level Increased, Myocardial Infarction
Adverse event resulted in: death
Drug(s) suspected as cause:
Namenda
Other drugs received by patient: Sitagliptin (Sitagliptin) (Sitagliptin); Quetiapine (Quetiapine) (Quetiapine); Donepezil (Donepezil) (Donepezil); Pioglitazone (Pioglitazone) (Pioglitazone); Darifenacin (Darifenacin) (Darifenacin)
Possible Namenda side effects in female
Reported by a physician from United States on 2011-11-04
Patient: female, weighing 56.7 kg (124.7 pounds)
Reactions: Chest Discomfort, Bundle Branch Block Left, Concomitant Disease Progression, Loss of Consciousness, Chest Pain, Dizziness, Acute Myocardial Infarction, Shock
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Namenda
Dosage: 10 mg, bid
Administration route: Oral
Indication: Dementia Alzheimer's Type
Start date: 2007-02-13
End date: 2007-05-13
Exelon
Dosage: 3 mg, bid
Administration route: Oral
Indication: Dementia Alzheimer's Type
Start date: 2007-02-13
End date: 2007-05-13
Other drugs received by patient: Warfarin Sodium; Toprol-XL; Lisinopril
|
